These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 29102125)

  • 1. Genetic and biological characterization of a Porcine Reproductive and Respiratory Syndrome Virus 2 (PRRSV-2) causing significant clinical disease in the field.
    Kvisgaard LK; Larsen LE; Hjulsager CK; Bøtner A; Rathkjen PH; Heegaard PMH; Bisgaard NP; Nielsen J; Hansen MS
    Vet Microbiol; 2017 Nov; 211():74-83. PubMed ID: 29102125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a modified-live virus vaccine in pigs experimentally infected with a highly pathogenic porcine reproductive and respiratory syndrome virus type 1 (HP-PRRSV-1).
    Canelli E; Catella A; Borghetti P; Ferrari L; Ogno G; De Angelis E; Bonilauri P; Guazzetti S; Nardini R; Martelli P
    Vet Microbiol; 2018 Nov; 226():89-96. PubMed ID: 30389048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.
    Evenson D; Gerber PF; Xiao CT; Halbur PG; Wang C; Tian D; Ni YY; Meng XJ; Opriessnig T
    Vaccine; 2016 Nov; 34(46):5546-5553. PubMed ID: 27742217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmission of Porcine reproductive and respiratory syndrome virus 1 to and from vaccinated pigs in a one-to-one model.
    Pileri E; Gibert E; Martín-Valls GE; Nofrarias M; López-Soria S; Martín M; Díaz I; Darwich L; Mateu E
    Vet Microbiol; 2017 Mar; 201():18-25. PubMed ID: 28284607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of simultaneous vaccination with two modified live virus vaccines against porcine reproductive and respiratory syndrome virus types 1 and 2 in pigs.
    Kristensen CS; Kvisgaard LK; Pawlowski M; Holmgaard Carlsen S; Hjulsager CK; Heegaard PMH; Bøtner A; Stadejek T; Haugegaard S; Larsen LE
    Vaccine; 2018 Jan; 36(2):227-236. PubMed ID: 29191738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous Infection With Porcine Reproductive and Respiratory Syndrome and Influenza Viruses Abrogates Clinical Protection Induced by Live Attenuated Porcine Reproductive and Respiratory Syndrome Vaccination.
    Chrun T; Maze EA; Vatzia E; Martini V; Paudyal B; Edmans MD; McNee A; Manjegowda T; Salguero FJ; Wanasen N; Koonpaew S; Graham SP; Tchilian E
    Front Immunol; 2021; 12():758368. PubMed ID: 34858411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular characteristic analysis of PRRSV GSWW/2015 strain and its pathogenicity to pigs.
    Bai W; Wang Z; Sun P; Zhang J; Bao H; Cao Y; Chang Y; Liu Z; Li D; Lu Z
    BMC Vet Res; 2018 Aug; 14(1):240. PubMed ID: 30119669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination against porcine reproductive and respiratory syndrome virus (PRRSV) reduces the magnitude and duration of viremia following challenge with a virulent heterologous field strain.
    Calvert JG; Keith ML; Pearce DS; Lenz MC; King VL; Diamondidis YA; Ankenbauer RG; Martinon NC
    Vet Microbiol; 2017 Jun; 205():80-83. PubMed ID: 28622868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two genetically distant type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccines against Vietnamese highly pathogenic PRRSV.
    Do DT; Park C; Choi K; Jeong J; Nguyen TT; Nguyen KD; Vo DT; Chae C
    Vet Microbiol; 2015 Sep; 179(3-4):233-41. PubMed ID: 26149103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Field Recombinant Strain Derived from Two Type 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV-1) Modified Live Vaccines Shows Increased Viremia and Transmission in SPF Pigs.
    Eclercy J; Renson P; Lebret A; Hirchaud E; Normand V; Andraud M; Paboeuf F; Blanchard Y; Rose N; Bourry O
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30909591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of modified-live porcine reproductive and respiratory syndrome virus (PRRSv) vaccine on the shedding of wild-type virus from an infected population of growing pigs.
    Linhares DC; Cano JP; Wetzell T; Nerem J; Torremorell M; Dee SA
    Vaccine; 2012 Jan; 30(2):407-13. PubMed ID: 22063389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterologous challenge with porcine reproductive and respiratory syndrome (PRRS) vaccine virus: no evidence of reactivation of previous European-type PRRS virus infection.
    Bøtner A; Nielsen J; Oleksiewicz MB; Storgaard T
    Vet Microbiol; 1999 Aug; 68(3-4):187-95. PubMed ID: 10510038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines.
    Geldhof MF; Van Breedam W; De Jong E; Lopez Rodriguez A; Karniychuk UU; Vanhee M; Van Doorsselaere J; Maes D; Nauwynck HJ
    Vet Microbiol; 2013 Dec; 167(3-4):260-71. PubMed ID: 24041768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with a genotype 1 modified live vaccine against porcine reproductive and respiratory syndrome virus significantly reduces viremia, viral shedding and transmission of the virus in a quasi-natural experimental model.
    Pileri E; Gibert E; Soldevila F; García-Saenz A; Pujols J; Diaz I; Darwich L; Casal J; Martín M; Mateu E
    Vet Microbiol; 2015 Jan; 175(1):7-16. PubMed ID: 25439650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity against a Japanese local strain of porcine reproductive and respiratory syndrome virus decreases viremia and symptoms of a highly pathogenic strain.
    Iseki H; Kawashima K; Shibahara T; Mase M
    BMC Vet Res; 2021 Apr; 17(1):156. PubMed ID: 33849520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Type 2 PRRSV vaccine against Chinese and Vietnamese HP-PRRSV challenge in pigs.
    Lager KM; Schlink SN; Brockmeier SL; Miller LC; Henningson JN; Kappes MA; Kehrli ME; Loving CL; Guo B; Swenson SL; Yang HC; Faaberg KS
    Vaccine; 2014 Nov; 32(48):6457-62. PubMed ID: 25285886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-protection of a modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-2 vaccine against a heterologous PRRSV-1 challenge in late-term pregnancy gilts.
    Jeong J; Park C; Oh T; Park KH; Yang S; Kang I; Park SJ; Chae C
    Vet Microbiol; 2018 Sep; 223():119-125. PubMed ID: 30173737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of four commercial PRRSV MLV vaccines in herds with co-circulation of PRRSV-1 and PRRSV-2.
    Oh T; Kim H; Park KH; Jeong J; Yang S; Kang I; Chae C
    Comp Immunol Microbiol Infect Dis; 2019 Apr; 63():66-73. PubMed ID: 30961820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Fostera PRRS modified live virus vaccine against a Canadian heterologous virulent field strain of porcine reproductive and respiratory syndrome virus.
    Savard C; Alvarez F; Provost C; Chorfi Y; D'Allaire S; Benoit-Biancamano MO; Gagnon CA
    Can J Vet Res; 2016 Jan; 80(1):1-11. PubMed ID: 26732457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commercial porcine reproductive and respiratory syndrome virus (PRRSV)-2 modified live virus vaccine against heterologous single and dual Korean PRRSV-1 and PRRSV-2 challenge.
    Jeong J; Kim S; Park C; Park KH; Kang I; Park SJ; Chae C
    Vet Rec; 2018 Apr; 182(17):485. PubMed ID: 29472439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.